Li W, Ji T, Ye J, Xiong S, Si Y, Sun X
Cancer Gene Ther. 2025; .
PMID: 40033102
DOI: 10.1038/s41417-025-00882-z.
Choi W, Lee J, Kim D, Ma E, Suh Y, Lee S
Front Physiol. 2024; 15:1467489.
PMID: 39397854
PMC: 11467469.
DOI: 10.3389/fphys.2024.1467489.
Saruuldalai E, Lee H, Lee Y, Hong E, Ro S, Kim Y
Mol Ther Nucleic Acids. 2024; 35(3):102270.
PMID: 39171141
PMC: 11338102.
DOI: 10.1016/j.omtn.2024.102270.
Hong J, Sohn K, Park H, Jeon H, Ju E, Lee J
Mol Ther Methods Clin Dev. 2024; 32(1):101202.
PMID: 38374964
PMC: 10875299.
DOI: 10.1016/j.omtm.2024.101202.
Ivanova A, Badertscher L, ODriscoll G, Bergman J, Gordon E, Gunnarsson A
Adv Sci (Weinh). 2023; 10(34):e2304389.
PMID: 37867228
PMC: 10700174.
DOI: 10.1002/advs.202304389.
Viral Shedding in Mice following Intravenous Adenovirus Injection: Impact on Biosafety Classification.
LaRocca C, Jacobsen K, Inoko K, Zakharkin S, Yamamoto M, Davydova J
Viruses. 2023; 15(7).
PMID: 37515182
PMC: 10385405.
DOI: 10.3390/v15071495.
An oncolytic adenovirus coding for a variant interleukin 2 cytokine improves response to chemotherapy through enhancement of effector lymphocyte cytotoxicity, fibroblast compartment modulation and mitotic slippage.
Pakola S, Quixabeira D, Kudling T, Clubb J, Gronberg-Vaha-Koskela S, Basnet S
Front Immunol. 2023; 14:1171083.
PMID: 37475863
PMC: 10354511.
DOI: 10.3389/fimmu.2023.1171083.
Interferon-expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model.
Shinoda S, Sharma N, Nakamura N, Inoko K, Sato-Dahlman M, Murugan P
Cancer Sci. 2023; 114(9):3759-3769.
PMID: 37439437
PMC: 10475772.
DOI: 10.1111/cas.15903.
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting.
Clubb J, Kudling T, Girych M, Haybout L, Pakola S, Hamdan F
Front Immunol. 2023; 14:1060540.
PMID: 36817448
PMC: 9936529.
DOI: 10.3389/fimmu.2023.1060540.
A host non-coding RNA, nc886, plays a pro-viral role by promoting virus trafficking to the nucleus.
Saruuldalai E, Park J, Kang D, Shin S, Im W, Lee H
Mol Ther Oncolytics. 2022; 24:683-694.
PMID: 35284627
PMC: 8904404.
DOI: 10.1016/j.omto.2022.02.018.
Human Adenovirus Species D Interactions with Corneal Stromal Cells.
Rajaiya J, Saha A, Zhou X, Chodosh J
Viruses. 2021; 13(12).
PMID: 34960773
PMC: 8709199.
DOI: 10.3390/v13122505.
Animal Models in Human Adenovirus Research.
Bertzbach L, Ip W, Dobner T
Biology (Basel). 2021; 10(12).
PMID: 34943168
PMC: 8698265.
DOI: 10.3390/biology10121253.
The Use of Oncolytic Viruses in the Treatment of Multiple Myeloma.
Stewart G, Chantry A, Lawson M
Cancers (Basel). 2021; 13(22).
PMID: 34830842
PMC: 8616105.
DOI: 10.3390/cancers13225687.
CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models.
Puigdelloses M, Garcia-Moure M, Labiano S, Laspidea V, Gonzalez-Huarriz M, Zalacain M
J Immunother Cancer. 2021; 9(7).
PMID: 34281988
PMC: 8291319.
DOI: 10.1136/jitc-2021-002644.
An Oncolytic Adenovirus Encoding SA-4-1BBL Adjuvant Fused to HPV-16 E7 Antigen Produces a Specific Antitumor Effect in a Cancer Mouse Model.
Martinez-Perez A, Perez-Trujillo J, Garza-Morales R, Ramirez-Avila N, Loera-Arias M, Gomez-Gutierrez J
Vaccines (Basel). 2021; 9(2).
PMID: 33673295
PMC: 7917608.
DOI: 10.3390/vaccines9020149.
Antitumor virotherapy using syngeneic or allogeneic mesenchymal stem cell carriers induces systemic immune response and intratumoral leukocyte infiltration in mice.
Morales-Molina A, Gambera S, Cejalvo T, Moreno R, Rodriguez-Milla M, Perise-Barrios A
Cancer Immunol Immunother. 2018; 67(10):1589-1602.
PMID: 30066102
PMC: 11028294.
DOI: 10.1007/s00262-018-2220-2.
Oncolytic adenoviruses as a therapeutic approach for osteosarcoma: A new hope.
Garcia-Moure M, Martinez-Velez N, Patino-Garcia A, Alonso M
J Bone Oncol. 2017; 9:41-47.
PMID: 29226089
PMC: 5715440.
DOI: 10.1016/j.jbo.2016.12.001.
Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model.
Rincon E, Cejalvo T, Kanojia D, Alfranca A, Rodriguez-Milla M, Gil Hoyos R
Oncotarget. 2017; 8(28):45415-45431.
PMID: 28525366
PMC: 5542197.
DOI: 10.18632/oncotarget.17557.
Ecdysone Receptor-based Singular Gene Switches for Regulated Transgene Expression in Cells and Adult Rodent Tissues.
Lee S, Sohn K, Choi D, Won M, Park K, Ju S
Mol Ther Nucleic Acids. 2016; 5(9):e367.
PMID: 27673563
PMC: 5056996.
DOI: 10.1038/mtna.2016.74.
Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice.
Cheng P, Rao X, Wechman S, Li X, McMasters K, Zhou H
BMC Cancer. 2015; 15:716.
PMID: 26475304
PMC: 4609153.
DOI: 10.1186/s12885-015-1731-x.